Intra-Trac® Oral Bb
Keeps social dogs and puppies protected against canine infectious tracheobronchitis due to Bordetella bronchiseptica.
Product Description
NOBIVAC® INTRA-TRAC® ORAL Bb provides protection against Canine Cough
Bordetella Bronchiseptica (Avirulent Live Culture).
- Easy to administer
- Free syringes with green plunger and marked ‘For Oral Use Only’ for easy distinguishing from other injectable vaccines
Indications
This product has been shown to be effective for vaccination of healthy dogs 7 weeks of age or older against Bordetella bronchiseptica.
NOBIVAC® INTRA-TRAC® ORAL BB IS A SAFE CHOICE
- In a field safety study in over 300 dogs the vaccine was proven safe86
- Proven safe across a multitude of dog breeds and ages
ADMINISTRATION AND DOSAGE
- Reconstitute the vaccine with the provided diluent
- Orally administer 1 mL of the vaccine into the buccal cavity
- Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. Contact your veterinarian or manufacturer for more information on revaccination frequency.
- Available in a 25x 1 mL dose presentation
ALSO AVAILABLE IN OTHER FORMULATIONS
DISEASE INFORMATION
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
View More Nobivac® ResourcesInfographic
Pair Up for Protection
When it comes to dogs in social environments, respiratory protection is essential. Use this conversation starter to discuss full respiratory protection with your clients
Digital Assets
Pair Up for Protection Social Media Kit
This vaccination season, use these ready-to-share posts to educate pet parents about the importance of full canine respiratory protection
eBook
Addressing CIV in Your Clinic
Tips and guidelines for your clinic to prevent and manage canine influenza.
References:
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global